KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Total Current Liabilities: 2009-2024

Historic Total Current Liabilities for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $994.1 million.

  • Charles River Laboratories International's Total Current Liabilities rose 10.83% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 10.83%. This contributed to the annual value of $994.1 million for FY2024, which is 5.78% down from last year.
  • As of FY2024, Charles River Laboratories International's Total Current Liabilities stood at $994.1 million, which was down 5.78% from $1.1 billion recorded in FY2023.
  • Charles River Laboratories International's 5-year Total Current Liabilities high stood at $1.1 billion for FY2022, and its period low was $839.8 million during FY2020.
  • Its 3-year average for Total Current Liabilities is $1.0 billion, with a median of $1.1 billion in 2023.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first increased by 23.03% in 2021, then fell by 5.78% in 2024.
  • Charles River Laboratories International's Total Current Liabilities (Yearly) stood at $839.8 million in 2020, then climbed by 23.03% to $1.0 billion in 2021, then rose by 5.65% to $1.1 billion in 2022, then declined by 3.34% to $1.1 billion in 2023, then decreased by 5.78% to $994.1 million in 2024.